Business
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
AUSTIN, Texas, January 12, 2026--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an advance in its universal influenza program following the identification of a breakthrough functional constraint that persists across influenza viruses despite continual evolution.
About this update from Mindwalk Holdings Corp.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/2494934d7af288d4fb023e02588b318b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MgTVo1AQ0IgZJacwoGYpbQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/2494934d7af288d4fb023e02588b318b","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/cZZhb_bE6c_qK94BdtWndg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/2494934d7af288d4fb023e02588b318b","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9","length":116,"tagName":"p","attribs":{}},{"type":"text","content":"AUSTIN, Texas, January 12, 2026--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) ("MindWalk" or the "Company"), a Bio-Native AI therapeutic research and technology company, today announced an advance in its universal influenza program following the identification of a breakthrough functional constraint that persists across influenza viruses despite continual evolution.","length":398,"tagName":"p"},{"type":"text","content":"Using its patented HYFT® Deep Data technology, MindWalk identified a functional pattern embedded in influenza biology that remains intact beneath surface-level genetic change. When MindWalk examines what does not change, it is not referring to conserved genetic sequences. It refers to preserved biological constraints; the biophysical requirements influenza must satisfy for infection.","length":386,"tagName":"p"},{"type":"text","content":"Influenza remains a major global health threat because influenza viruses continually alter immune-exposed regions of surface proteins, eroding durable protection and forcing reactive vaccine redesign. Current U.S. surveillance reflects unusually high influenza activity, described in public reporting as the highest level in approximately 25 years.","length":348,"tagName":"p"},{"type":"text","content":"Why Influenza Keeps Beating Conventional Vaccines","length":49,"tagName":"p"},{"type":"text","content":"Most influenza research relies on tra...